General introduction and thesis outline 31 106. Eisenberg ML, Shinohara K. Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure. Urology 2008;72:1315–8. 107. Peters M, Kanthabalan A, Shah TT, McCartan N, Moore CM, Arya M, et al. Development and internal validation of prediction models for biochemical failure and composite failure after focal salvage high intensity focused ultrasound for local radiorecurrent prostate cancer: Presentation of risk scores for individual patient progn. Urol Oncol Semin Orig Investig 2018;36:13.e1-13.e10. 108. Kanthabalan A, Peters M, Van Vulpen M, McCartan N, Hindley RG, Emara A, et al. Focal salvage highintensity focused ultrasound in radiorecurrent prostate cancer. BJU Int 2017;120:246–56. 109. Ahmed HU, Cathcart P, McCartan N, Kirkham A, Allen C, Freeman A, et al. Focal salvage therapy for localised prostate cancer recurrence after external beam radiotherapy: a pilot study. Cancer 2012;118:4148–55. 110. Baco E, Gelet A, Crouzet S, Rud E, Rouvière O, TonoliCatez H, et al. Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study. BJU Int 2014;114:532–40. 111. Overduin CG, Jenniskens SFM, Sedelaar JPM, Bomers JGR, Fütterer JJ. Percutaneous MR-guided focal cryoablation for recurrent prostate cancer following radiation therapy: retrospective analysis of iceball margins and outcomes. Eur Radiol 2017;27:4828–36. 112. van Son MJ, Peters M, Moerland MA, Lagendijk JJW, Eppinga WSC, Shah TT, et al. MRI-Guided Ultrafocal Salvage High-Dose-Rate Brachytherapy for Localised Radiorecurrent Prostate Cancer: Updated Results of 50 Patients. Int J Radiat Oncol 2020;107(1):126-135. 113. van Son M, Peters M, Moerland M, van de Pol S, Eppinga W, Lagendijk J, et al. Determining the safety of ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: A toxicity assessment of 150 patients. Clin Transl Radiat Oncol 2021;27:1–7. 114. Jiang P, van der Horst C, Kimmig B, Zinsser F, Poppe B, Luetzen U, et al. Interstitial high-dose-rate brachytherapy as salvage treatment for locally recurrent prostate cancer after definitive radiation therapy: Toxicity and 5-year outcome. Brachytherapy 2017;16:186–92. 115. Jereczek-Fossa BA, Beltramo G, Fariselli L, Fodor C, Santoro L, Vavassori A, et al. Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer. Int J Radiat Oncol Biol Phys 2012;82:889–97. 116. Mbeutcha A, Chauveinc L, Bondiau PY, Chand ME, Durand M, Chevallier D, et al. Salvage prostate reirradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy. Radiat Oncol 2017;12:1–10. 117. Janoray G, Reynaud-Bougnoux A, Ruffier-Loubière A, Bernadou G, Pointreau Y, Calais G. Stereotactic body re-irradiation therapy for locally recurrent prostate cancer after external-beam radiation therapy: Initial report. Cancer Radiother 2016;20:275–81. 118. Pasquier D, Martinage G, Janoray G, Rojas DP, Zerini D, Goupy F, et al. Salvage Stereotactic Body Radiation Therapy for Local Prostate Cancer Recurrence After Radiation Therapy: A Retrospective Multicenter Study of the GETUG. Int J Radiat Oncol Biol Phys 2019;105:727–34. 119. Loi M, Di Cataldo V, Simontacchi G, Detti B, Bonomo P, Masi L, et al. Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer. Clin Oncol (R Coll Radiol) 2018;30:93–100. 120. Jereczek-Fossa BA, Rojas DP, Zerini D, Fodor C, Viola A, Fanetti G, et al. Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT). Br J Radiol 2019;92:20180494. 121. Scher N, Bauduceau O, Bollet M, Lamallem H, Charas T, Garaud P, et al. Stereotactic prostate focal reirradiation therapy for local recurrence: preliminary results of Hartmann Oncology Radiotherapy Group. BJR Open 2019;1:20180027. 1
RkJQdWJsaXNoZXIy MTk4NDMw